Hyaluronan Depolymerization by Megakaryocyte Hyaluronidase-2 Is Required for Thrombopoiesis

Area of Science:

• Extracellular matrix biology
• Hematopoiesis and cell differentiation
• Glycosaminoglycan metabolism

Background:

• Hyaluronan (HA) is a key extracellular matrix component regulating cellular functions.
• HA's molecular size, determined by synthesis and degradation, is crucial for its biological activity.
• Mammalian hyaluronidases, particularly hyaluronidase-2 (Hyal-2), are involved in HA degradation, but their role in platelet production is unclear.

Purpose of the Study:

• To investigate the role of hyaluronidase-2 (Hyal-2) in megakaryopoiesis and platelet production.
• To elucidate the mechanism by which Hyal-2 deficiency leads to thrombocytopenia.

Main Methods:

• Utilized hyaluronidase-2 (Hyal-2) knockout mouse models.
• Analyzed hyaluronan accumulation in bone marrow and megakaryocytes.
• Examined proplatelet formation and demarcation membrane system development in megakaryocytes.
• Assessed the therapeutic potential of exogenous hyaluronidase administration.

Main Results:

• Hyal-2 knockout mice exhibited significant hyaluronan accumulation in bone marrow and megakaryocytes.
• Megakaryocytes from Hyal-2 knockout mice showed impaired proplatelet formation due to defective demarcation membrane system.
• Treatment with exogenous hyaluronidase restored proplatelet formation in both murine and human Hyal-2 deficient megakaryocytes.

Conclusions:

• Hyaluronidase-2 (Hyal-2) plays a critical role in regulating hyaluronan levels within the bone marrow niche.
• Hyal-2 deficiency disrupts megakaryocyte function and platelet generation through altered hyaluronan metabolism.
• Targeting hyaluronidase activity presents a potential therapeutic strategy for thrombocytopenia associated with Hyal-2 dysfunction.